AMT - Allegra Medical Technologies

[System]

Advanced Surgical Design & Manufacture Limited (AMT) is engaged in the research, product development and manufacturing of medical devices including prosthetic implant tools. The Company focuses on providing health care solutions to patients through harnessing the innovative potential of Australian inventors and clinicians.

www.asdm.com.au

 

[System]

On December 3rd, 2014, Advanced Surgical Design & Manufacture Limited changed its name to Allegra Orthopaedics Limited.

 

[Dona Ferentes]

6 years and bouncing along

AMT probably a nice little earner for the management; it is (still) "engaged in sale, design and distribution of its medical device product range within its Orthopaedic Division and within the Innovation Division, advancing the development and commercialisation of innovative technologies into products which can be taken to market."

Not even Covid could give it a boost ('Supply of Australian made TGA approved face shields")

 

[Trav.]

AMT probably a nice little earner for the management

Unfortunately these are the only ones who generally make any money in these types of companies.

 

[Dona Ferentes]

and then, someone does

 

[Dona Ferentes]

Today, announcing the successful acquisition of all the registered patents and application for patents held by the by the University of Sydney in relation to a unique bio ceramic material known as Sr-HT-Gahnite. This material can be utilised in a variety of applications including its use as a synthetic bone substitute.

As consideration for this acquisition, Allegra has today issued to the University of Sydney 4,806,000 ordinary shares in Allegra. Allegra began collaborating with the University of Sydney in 2014 when the Company exclusively licensed the Sr-HT-Gahnite from the University of Sydney.

The outstanding capacity of the Sr-HT-Gahnite material is to simulate the performance of natural bone by achieving the mechanical strength required for load-bearing application and the bioactivity for bone regeneration, as well as resorbability for reducing long-term complications, and the ability to be 3D printed. This has enabled Allegra to work towards developing and commercializing implants that offer a revolutionary approach to surgeries.

 

[barney]

Today, announcing the successful acquisition of all the registered patents and application for patents held by the by the University of Sydney

I thought you may have spotted this one "DF" ....

I have little idea of the value of the announcement, but it's not often you see a Stock jump over 500% in a day Nice for anyone holding

 

[Dona Ferentes]

I thought you may have spotted this one "DF" ....

I have little idea of the value of the announcement, but it's not often you see a Stock jump over 500% in a day Nice for anyone holding

Not an inkling.

 

[Dona Ferentes]

All patents for the 3D printable artificial bone held by University of Sydney have been purchased by AMT. Results from the large animal trial should be released soon which will lead (if reported as successful) to the first human spinal implant. The CEO told me at the 2018 AGM (only 2 shareholders present) that they have patents over virtually every bone in the body. I was allowed to hold the Sr-HT-Gahnite spinal cage that will be used in the first human trial. The trials have been designed in conjunction with the FDA.

“ The medical device is a 3D printed bioceramic scaffold with outstanding potential for supporting bone regeneration in load bearing applications. Current synthetic bone substitutes, of over 150 products, either regenerate bone or weight-bear. Sr-HT-Gahnite is capable of doing both!”

thanks to juxtaposer at SC

 

[System]

On November 6th, 2023, Allegra Orthopaedics Limited changed its name to Allegra Medical Technologies Limited.

 

[Dona Ferentes]

and how's this li'l beaudy coming along?

.
not that well, it would seem. Recently, by August the orthopaedics division was sold, and they went to the market to raise for the new direction, a cervical spinal cage.

Wanted to raise $3+M at $0.09 but fell short. (optimistic, I'd have thought) (and likely not the last)

....the clanger:
Cash Raised from the Entitlement Offer
As part of the Entitlement acceptances, the consideration for 12,758,316 shares (equal to approximately $1.148m) was paid through the part settlement of the equivalent value of the Convertible Loan Agreement with Robinwood Investments Pty Ltd. As such, the net cash raised from the Offer is approximately $215k (before costs).

 

[System]

On November 14th, 2024, Allegra Medical Technologies Limited (AMT) was removed from the ASX's Official List in accordance with Listing Rule 17.14, following compulsory acquisition of its remaining securities by Allegra Innovations Pty Ltd.